Stock of Interest

Posted On: September 21, 2023

Stock Report: FDC(NSE) 20 Sep 2023 

FDC Ltd is an Indian-based pharmaceutical company with USFDA and UK-MHRA-approved API and formulations manufacturing facilities. It has its presence in numerous therapeutic segments: Anti-infectives, Gastro-Intestinal, Vitamins/Minerals/Nutrients, Ophthalmology/Otologicals, Cardiac, Dermatology, Respiratory, Gynaecology, and Others. The company’s brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The majority of the revenue is generated domestically.

#xCalData predicts that # FDC will continue its bearish phase over the next five days and trend within the range of 334 to 365. 

In comparison to the previous month, the price of the stock has experienced a decline of 6.96% indicating a bearish. 

The Stock has doubled once since 27 Mar 2015 and took an average of 2.9 years to double. 

The stock has shown seasonality trend in the past. 

Reviewing the returns for the past 5 years for the same week, we see the stock has given negative returns in 4 years in the past.  

Majority of the technical ratios trend towards Bearish side of the spectrum. Only some of the technical indicators namely Relative Strength indicate Bullish view. 

Collectively, xCalData suggests the stock would be in Bearish zone for next 5 days. 

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData